UBS upgraded Compass (COMP) to Buy from Neutral with a price target of $11, up from $7. The shares are not pricing in the benefits of the recently-closed Christie’s acquisition or Compass’s ability to drive organic market share gains, the analyst tells investors in a research note. The firm says the company’s execution track record on organic growth and cost containment remains underappreciated at current share levels. UBS sees “asymmetric upside” from a potentially favorable Clear Cooperation Policy decision, accelerated home purchase activity in Los Angeles post wildfires, upside to the $30M of acquisition related cost savings over the next three years, and the potential for existing home sales trends to accelerate in the second half of 2025.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.